JACLYN FINAMORE: Open Payments
NPI 1801136338 · BOARDMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 37 payments from 4 companies in 2025. Trend: 2023 $812 · 2024 $277 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 23 | $202 |
| MILLICENT US INC | 9 | $146 |
| Exeltis, USA Inc. | 4 | $82 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: FEMRING, SLYND, FEMLYV, MYFEMBREE, INTRAROSA.
Industry payments across OH — which companies pay providers there.
